...
首页> 外文期刊>Oncology reports >Ultrasound-targeted microbubble destruction of calcium channel subunit alpha 1D siRNA inhibits breast cancer via G protein-coupled receptor 30
【24h】

Ultrasound-targeted microbubble destruction of calcium channel subunit alpha 1D siRNA inhibits breast cancer via G protein-coupled receptor 30

机译:超声靶向的微气泡破坏钙通道亚基α1D siRNA通过G蛋白偶联受体30抑制乳腺癌

获取原文
获取原文并翻译 | 示例

摘要

Estrogen has been closely associated with breast cancer. Several studies reported that Ca2+ signal and Ca2+ channels act in estrogen-modulated non-genomic pathway of breast cancer, however little was revealed on the function of L-type Ca2+ channels. The L-type Ca2+ channel subunit alpha 1D, named Cav1.3 was found in breast cancer cells. We aimed to investigate the expression and activity of Cav1.3 in human breast cancer, and reveal the effect of estrogen in regulating the expression of Cav1.3. The qRT-PCR and western blotting were employed to show that Cav1.3 was highly expressed in breast cancer tissues. E2 exposure rapidly upregulated the expression of Cav1.3 in dosage- and time-dependent manner, and promoted Ca2+ influx. The silencing of G protein-coupled estrogen receptor 30 (GPER1/GPR30) using siRNA transfection inhibited the upregulation of Cav1.3 and Ca2+ influx induced by E2. Moreover, the inhibition of Cav1.3 by siRNA transfection suppressed E2-induced second peak of Ca2+ signal, the expression of p-ERK1/2, and the cell proliferation. Ultrasound-targeted microbubble destruction (UTMD) of Cav1.3 siRNA was used in MCF-7 cells in vitro and in the tumor xenografts mice in vivo. The application of UTMD significantly suppressed the tumor growth and promoted the survival rate. In conclusion, E2 upregulated the expression of Cav1.3 for Ca2+ influx to promote the expression of p-ERK1/2 for cell proliferation. The study confirmed that the mechanism of E2 inducing the expression of Cav1.3 through a non-genomic pathway, and highlighted that UTMD of Cav1.3 siRNA is a powerful promising technology for breast cancer gene therapy.
机译:雌激素与乳腺癌密切相关。几项研究报道,Ca2 +信号和Ca2 +通道在乳腺癌的雌激素调节性非基因组途径中起作用,但是关于L型Ca2 +通道的功能却很少。在乳腺癌细胞中发现了名为Cav1.3的L型Ca2 +通道亚基alpha 1D。我们旨在研究Cav1.3在人类乳腺癌中的表达和活性,并揭示雌激素在调节Cav1.3表达中的作用。使用qRT-PCR和Western blotting证明Cav1.3在乳腺癌组织中高表达。 E2暴露以剂量和时间依赖性方式迅速上调Cav1.3的表达,并促进Ca2 +内流。使用siRNA转染沉默G蛋白偶联雌激素受体30(GPER1 / GPR30)抑制了E2诱导的Cav1.3和Ca2 +内流上调。此外,siRNA转染对Cav1.3的抑制作用可抑制E2诱导的Ca2 +信号第二个峰,p-ERK1 / 2的表达以及细胞增殖。 Cav1.3 siRNA的超声靶向微泡破坏(UTMD)用于体外MCF-7细胞和体内肿瘤异种移植小鼠。 UTMD的应用显着抑制了肿瘤的生长并提高了存活率。总之,E2上调Caav +内流的Cav1.3表达,从而促进p-ERK1 / 2的表达促进细胞增殖。这项研究证实了E2通过非基因组途径诱导Cav1.3表达的机制,并强调了Cav1.3 siRNA的UTMD是一种强有力的有前途的乳腺癌基因治疗技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号